Patients and methods This investigation was started as a case-control study to determine the preventive effect of oral contraceptive use on the incidence of RA. 26 The study was started in 1984 at the department of rheumatology of the Leiden University Hospital in the Netherlands, which is the only referral clinic for rheumatic disorders in a district of about 300 000 inhabitants. All consecutive women who attended the outpatient clinic for the first time between 1982 and 1986 who had recent symptoms of RA (less than five years) and who were aged 20-50 years at the first visit were initially considered. Patients with RA were defined as those who fulfilled the American Rheumatism Association (ARA) criteria for definite RA.27 Later in the study it was also noted whether the patients with RA met the new ARA criteria for RA28 at some time during the course of the disease. In total 138 patients with definite RA entered the study.
FOLLOW UP OF PATIENTS
The patients with RA were seen once a year with each examination consisting of a detailed interview, physical examination, assessment of functional ability, scoring of wrist, hand, and foot radiographs, and collection of serum samples. Throughout the study clinical assessments were made by two of us (JMWH and DvZ).
Prescribed second line drugs (hydroxychloroquine, gold salts, sulphasalazine, D-penicillamine, azathioprine, methotrexate, and cyclosporine) were noted.
The joints were examined for tenderness, Waaler-Rose and latex tests were performed from the beginning of the study whereas RF isotypes were measured later from stored serum samples which were collected only after 1984. individual patients was calculated. Table 3 gives the results of this analysis. Analysis focused on the prognostic value of the different RF tests showed that there were more erosions after six years of follow up from the onset of symptoms in patient groups with moderately or strongly increased results of the RF tests measured within the first three years from the onset of symptoms than in patients with RF levels within the range of healthy controls. Furthermore for the latex, IgM, IgA and IgG RF tests there were more erosions in patients with strongly increased RF levels than in patients with moderately increased levels. Comparison of absolute RF levels with the number of erosions showed the strongest correlation for IgA RF. Analysis of the prognostic value of the different RF tests with regard to parameters of disease activity, functional ability, and the need for second line drug treatment showed that patients with moderately or strongly increased RF levels tended to have higher values of these parameters than patients with RF levels within the range of healthy controls. symptoms with more radiological abnormalities and worse functional ability after a mean follow up of 10 years. Furthermore the levels of IgM and IgA RF were correlated with the time of onset of erosions. In a third study23 with a follow up duration of two years both an initially positive IgM and IgA RF test were predictive for the development of more erosions. The differences were small, however, and not statistically significant. In a fourth study with a follow up duration of one year no correlation was found between the levels of serum RF isotypes and the Ritchie articular index either at the time of testing, within 18 months of the onset of symptoms, or one year later. In a fifth study24 neither a positive Waaler-Rose test nor positive IgM, IgA, and IgG RF test within two years of the diagnosis RA were associated with the presence of radiological abnormalities after two years of follow up. An expansion of this study has now been published25 and except for a correlation between IgG RF levels and the change in progression rate between radiological scores in the first and second year no associations were found between rheumatoid factor isotypes and radiological abnormalities.
CORRELATION OF RF LEVELS
Discrepancies between the results of various studies of the association between clinical parameters of RA and serum RF isotypes may be due to several factors. There were considerable differences in patient selection and study design as well as differences in the techniques used to measure RF isotypes. The results of this study suggest an additional factor, namely the absence of any one particular RF isotype which is particularly related to the manifestations of RA. The serum levels of the different RF isotypes appeared to be highly correlated and no RF isotype measured during the course of the disease was clearly superior with respect to the association with disease parameters.
Many laboratories will replace the agglutination tests by the ELISA for the detection of RF. ELISAs are more sensitive, easier to perform, and more reproducible than the conventional agglutination tests.6 7 35 As the introduction of this test offers the possibility of obtaining information on RF isotypes the question arises as to which information is most useful for evaluating the severity of the disease. (The value of RF isotypes in the diagnostic process was not addressed in this study.) All 
